Global Ketoconazole Market

Ketoconazole Comprehensive Study by Type (Ketoconazole Oral, Ketoconazole Topical), Application (Psoriasis, Tinea infections, Hair loss), Distribution Channel (Online Retail, Offline Retail) Players and Region - Global Market Outlook to 2030

Ketoconazole Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Ketoconazole
Ketoconazole belongs to the drug class azole antifungals. It is antifungal in nature. It is used in the treatment of skin, nails, and other infections. It is also used in the treatment of psoriasis, tinea infections, and hair loss. The increasing number of people with hair problems driving the demand for ketoconazole. Further, growing healthcare infrastructure in the developing economies and technological advancement in the healthcare industry expected to drive the demand for ketoconazole over the forecasted period.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Analyst at AMA Research estimates that United States Vendors will contribute the maximum growth to Global Ketoconazole market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Mylan (United States), Almirall (Spain), Johnson & Johnson (United States), Taro Pharmaceutical (Israel), Teva Pharmaceutical (Israel), Novartis (Switzerland), GlaxoSmithKline (United Kingdom), Amgen (United States), AbbVie (United States) and Merck & Co (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Strides Pharma (India), Parchem (United States), Ciron Drugs and Pharmaceuticals P Ltd (India) and Bristol-Myers Squibb (United States).

Segmentation Overview
AMA Research has segmented the market of Global Ketoconazole market by Type (Ketoconazole Oral and Ketoconazole Topical), Application (Psoriasis, Tinea infections and Hair loss) and Region.



On the basis of geography, the market of Ketoconazole has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online Retail will boost the Ketoconazole market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Applications as Antifungal Medication in Case of Skin, Ringworm, and Other Infections and Advancement in the Healthcare Industry

Market Growth Drivers:
Rising Prevalence of Hair Related Problems Such As Hair Loss and Others and Growing Healthcare Infrastructure in the Developing Economies

Challenges:
Lack of Awareness in the Low and Middle Income Group Countries

Restraints:
Stringent Government Regulations Regarding Medications and Side Effects Such As Redness, Swelling, and Others

Opportunities:
Rising Demand from the Developing Economies and Increasing Number of Clinical Trials

Market Leaders and their expansionary development strategies
In June 2018, Kramer Laboratories, Inc., a marketer of over-the-counter (OTC) foot care and specialty cough products, announced the acquisition, a leading anti-dandruff shampoo brand sold in North America and Latin America, from Janssen Pharmaceutica NV (a member of the Johnson & Johnson family of companies). Kramer is a portfolio company of Avista Capital Partners, a leading healthcare-focused private equity firm, and Dana Holdings, a consumer healthcare-focused private investment group.
In August 2021, Insud Pharmaceuticals, announced the launch of Ketoconazole Foam, 2%, generic to Extina. Xiromed is focused on expanding the range of dosage forms offered in portfolio, and the launch of Ketoconazole Foam, 2% demonstrates our commitment to expansion into a wide variety of dosage forms.
“The U.S. Food and Drug Administration (FDA) is taking several actions related to Nizoral (ketoconazole) oral tablets, including limiting the drug’s use, warning that it can cause severe liver injuries and adrenal gland problems and advising that it can lead to harmful drug interactions with other medications. FDA has approved label changes and added a new Medication Guide to address these safety issues. As a result, Nizoral oral tablets should not be a first-line treatment for any fungal infection. Nizoral should be used for the treatment of certain fungal infections, known as endemic mycoses, only when alternative antifungal therapies are not available or tolerated.”

Key Target Audience
Manufacturers of ketoconazole, Distributors of ketoconazole, Potential Investors, Associations, Organizations, Forums, and Alliances, Government Bodies and Departments, Research Institutes, Business Consulting Firms and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Ketoconazole Oral
  • Ketoconazole Topical
By Application
  • Psoriasis
  • Tinea infections
  • Hair loss
By Distribution Channel
  • Online Retail
  • Offline Retail

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Hair Related Problems Such As Hair Loss and Others
      • 3.2.2. Growing Healthcare Infrastructure in the Developing Economies
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in the Low and Middle Income Group Countries
    • 3.4. Market Trends
      • 3.4.1. Rising Applications as Antifungal Medication in Case of Skin, Ringworm, and Other Infections
      • 3.4.2. Advancement in the Healthcare Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ketoconazole, by Type, Application, Distribution Channel and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Ketoconazole (Value)
      • 5.2.1. Global Ketoconazole by: Type (Value)
        • 5.2.1.1. Ketoconazole Oral
        • 5.2.1.2. Ketoconazole Topical
      • 5.2.2. Global Ketoconazole by: Application (Value)
        • 5.2.2.1. Psoriasis
        • 5.2.2.2. Tinea infections
        • 5.2.2.3. Hair loss
      • 5.2.3. Global Ketoconazole by: Distribution Channel (Value)
        • 5.2.3.1. Online Retail
        • 5.2.3.2. Offline Retail
      • 5.2.4. Global Ketoconazole Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Ketoconazole: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mylan (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Almirall (Spain)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Taro Pharmaceutical (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Teva Pharmaceutical (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novartis (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GlaxoSmithKline (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Amgen (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. AbbVie (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck & Co (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Ketoconazole Sale, by Type, Application, Distribution Channel and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Ketoconazole (Value)
      • 7.2.1. Global Ketoconazole by: Type (Value)
        • 7.2.1.1. Ketoconazole Oral
        • 7.2.1.2. Ketoconazole Topical
      • 7.2.2. Global Ketoconazole by: Application (Value)
        • 7.2.2.1. Psoriasis
        • 7.2.2.2. Tinea infections
        • 7.2.2.3. Hair loss
      • 7.2.3. Global Ketoconazole by: Distribution Channel (Value)
        • 7.2.3.1. Online Retail
        • 7.2.3.2. Offline Retail
      • 7.2.4. Global Ketoconazole Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ketoconazole: by Type(USD Million)
  • Table 2. Ketoconazole Ketoconazole Oral , by Region USD Million (2018-2023)
  • Table 3. Ketoconazole Ketoconazole Topical , by Region USD Million (2018-2023)
  • Table 4. Ketoconazole: by Application(USD Million)
  • Table 5. Ketoconazole Psoriasis , by Region USD Million (2018-2023)
  • Table 6. Ketoconazole Tinea infections , by Region USD Million (2018-2023)
  • Table 7. Ketoconazole Hair loss , by Region USD Million (2018-2023)
  • Table 8. Ketoconazole: by Distribution Channel(USD Million)
  • Table 9. Ketoconazole Online Retail , by Region USD Million (2018-2023)
  • Table 10. Ketoconazole Offline Retail , by Region USD Million (2018-2023)
  • Table 11. South America Ketoconazole, by Country USD Million (2018-2023)
  • Table 12. South America Ketoconazole, by Type USD Million (2018-2023)
  • Table 13. South America Ketoconazole, by Application USD Million (2018-2023)
  • Table 14. South America Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 15. Brazil Ketoconazole, by Type USD Million (2018-2023)
  • Table 16. Brazil Ketoconazole, by Application USD Million (2018-2023)
  • Table 17. Brazil Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 18. Argentina Ketoconazole, by Type USD Million (2018-2023)
  • Table 19. Argentina Ketoconazole, by Application USD Million (2018-2023)
  • Table 20. Argentina Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 21. Rest of South America Ketoconazole, by Type USD Million (2018-2023)
  • Table 22. Rest of South America Ketoconazole, by Application USD Million (2018-2023)
  • Table 23. Rest of South America Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 24. Asia Pacific Ketoconazole, by Country USD Million (2018-2023)
  • Table 25. Asia Pacific Ketoconazole, by Type USD Million (2018-2023)
  • Table 26. Asia Pacific Ketoconazole, by Application USD Million (2018-2023)
  • Table 27. Asia Pacific Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 28. China Ketoconazole, by Type USD Million (2018-2023)
  • Table 29. China Ketoconazole, by Application USD Million (2018-2023)
  • Table 30. China Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 31. Japan Ketoconazole, by Type USD Million (2018-2023)
  • Table 32. Japan Ketoconazole, by Application USD Million (2018-2023)
  • Table 33. Japan Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 34. India Ketoconazole, by Type USD Million (2018-2023)
  • Table 35. India Ketoconazole, by Application USD Million (2018-2023)
  • Table 36. India Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 37. South Korea Ketoconazole, by Type USD Million (2018-2023)
  • Table 38. South Korea Ketoconazole, by Application USD Million (2018-2023)
  • Table 39. South Korea Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 40. Taiwan Ketoconazole, by Type USD Million (2018-2023)
  • Table 41. Taiwan Ketoconazole, by Application USD Million (2018-2023)
  • Table 42. Taiwan Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 43. Australia Ketoconazole, by Type USD Million (2018-2023)
  • Table 44. Australia Ketoconazole, by Application USD Million (2018-2023)
  • Table 45. Australia Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 46. Rest of Asia-Pacific Ketoconazole, by Type USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Ketoconazole, by Application USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 49. Europe Ketoconazole, by Country USD Million (2018-2023)
  • Table 50. Europe Ketoconazole, by Type USD Million (2018-2023)
  • Table 51. Europe Ketoconazole, by Application USD Million (2018-2023)
  • Table 52. Europe Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 53. Germany Ketoconazole, by Type USD Million (2018-2023)
  • Table 54. Germany Ketoconazole, by Application USD Million (2018-2023)
  • Table 55. Germany Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 56. France Ketoconazole, by Type USD Million (2018-2023)
  • Table 57. France Ketoconazole, by Application USD Million (2018-2023)
  • Table 58. France Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 59. Italy Ketoconazole, by Type USD Million (2018-2023)
  • Table 60. Italy Ketoconazole, by Application USD Million (2018-2023)
  • Table 61. Italy Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 62. United Kingdom Ketoconazole, by Type USD Million (2018-2023)
  • Table 63. United Kingdom Ketoconazole, by Application USD Million (2018-2023)
  • Table 64. United Kingdom Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 65. Netherlands Ketoconazole, by Type USD Million (2018-2023)
  • Table 66. Netherlands Ketoconazole, by Application USD Million (2018-2023)
  • Table 67. Netherlands Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 68. Rest of Europe Ketoconazole, by Type USD Million (2018-2023)
  • Table 69. Rest of Europe Ketoconazole, by Application USD Million (2018-2023)
  • Table 70. Rest of Europe Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 71. MEA Ketoconazole, by Country USD Million (2018-2023)
  • Table 72. MEA Ketoconazole, by Type USD Million (2018-2023)
  • Table 73. MEA Ketoconazole, by Application USD Million (2018-2023)
  • Table 74. MEA Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 75. Middle East Ketoconazole, by Type USD Million (2018-2023)
  • Table 76. Middle East Ketoconazole, by Application USD Million (2018-2023)
  • Table 77. Middle East Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 78. Africa Ketoconazole, by Type USD Million (2018-2023)
  • Table 79. Africa Ketoconazole, by Application USD Million (2018-2023)
  • Table 80. Africa Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 81. North America Ketoconazole, by Country USD Million (2018-2023)
  • Table 82. North America Ketoconazole, by Type USD Million (2018-2023)
  • Table 83. North America Ketoconazole, by Application USD Million (2018-2023)
  • Table 84. North America Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 85. United States Ketoconazole, by Type USD Million (2018-2023)
  • Table 86. United States Ketoconazole, by Application USD Million (2018-2023)
  • Table 87. United States Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 88. Canada Ketoconazole, by Type USD Million (2018-2023)
  • Table 89. Canada Ketoconazole, by Application USD Million (2018-2023)
  • Table 90. Canada Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 91. Mexico Ketoconazole, by Type USD Million (2018-2023)
  • Table 92. Mexico Ketoconazole, by Application USD Million (2018-2023)
  • Table 93. Mexico Ketoconazole, by Distribution Channel USD Million (2018-2023)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Ketoconazole: by Type(USD Million)
  • Table 105. Ketoconazole Ketoconazole Oral , by Region USD Million (2025-2030)
  • Table 106. Ketoconazole Ketoconazole Topical , by Region USD Million (2025-2030)
  • Table 107. Ketoconazole: by Application(USD Million)
  • Table 108. Ketoconazole Psoriasis , by Region USD Million (2025-2030)
  • Table 109. Ketoconazole Tinea infections , by Region USD Million (2025-2030)
  • Table 110. Ketoconazole Hair loss , by Region USD Million (2025-2030)
  • Table 111. Ketoconazole: by Distribution Channel(USD Million)
  • Table 112. Ketoconazole Online Retail , by Region USD Million (2025-2030)
  • Table 113. Ketoconazole Offline Retail , by Region USD Million (2025-2030)
  • Table 114. South America Ketoconazole, by Country USD Million (2025-2030)
  • Table 115. South America Ketoconazole, by Type USD Million (2025-2030)
  • Table 116. South America Ketoconazole, by Application USD Million (2025-2030)
  • Table 117. South America Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 118. Brazil Ketoconazole, by Type USD Million (2025-2030)
  • Table 119. Brazil Ketoconazole, by Application USD Million (2025-2030)
  • Table 120. Brazil Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 121. Argentina Ketoconazole, by Type USD Million (2025-2030)
  • Table 122. Argentina Ketoconazole, by Application USD Million (2025-2030)
  • Table 123. Argentina Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 124. Rest of South America Ketoconazole, by Type USD Million (2025-2030)
  • Table 125. Rest of South America Ketoconazole, by Application USD Million (2025-2030)
  • Table 126. Rest of South America Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 127. Asia Pacific Ketoconazole, by Country USD Million (2025-2030)
  • Table 128. Asia Pacific Ketoconazole, by Type USD Million (2025-2030)
  • Table 129. Asia Pacific Ketoconazole, by Application USD Million (2025-2030)
  • Table 130. Asia Pacific Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 131. China Ketoconazole, by Type USD Million (2025-2030)
  • Table 132. China Ketoconazole, by Application USD Million (2025-2030)
  • Table 133. China Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 134. Japan Ketoconazole, by Type USD Million (2025-2030)
  • Table 135. Japan Ketoconazole, by Application USD Million (2025-2030)
  • Table 136. Japan Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 137. India Ketoconazole, by Type USD Million (2025-2030)
  • Table 138. India Ketoconazole, by Application USD Million (2025-2030)
  • Table 139. India Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 140. South Korea Ketoconazole, by Type USD Million (2025-2030)
  • Table 141. South Korea Ketoconazole, by Application USD Million (2025-2030)
  • Table 142. South Korea Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 143. Taiwan Ketoconazole, by Type USD Million (2025-2030)
  • Table 144. Taiwan Ketoconazole, by Application USD Million (2025-2030)
  • Table 145. Taiwan Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 146. Australia Ketoconazole, by Type USD Million (2025-2030)
  • Table 147. Australia Ketoconazole, by Application USD Million (2025-2030)
  • Table 148. Australia Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 149. Rest of Asia-Pacific Ketoconazole, by Type USD Million (2025-2030)
  • Table 150. Rest of Asia-Pacific Ketoconazole, by Application USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 152. Europe Ketoconazole, by Country USD Million (2025-2030)
  • Table 153. Europe Ketoconazole, by Type USD Million (2025-2030)
  • Table 154. Europe Ketoconazole, by Application USD Million (2025-2030)
  • Table 155. Europe Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 156. Germany Ketoconazole, by Type USD Million (2025-2030)
  • Table 157. Germany Ketoconazole, by Application USD Million (2025-2030)
  • Table 158. Germany Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 159. France Ketoconazole, by Type USD Million (2025-2030)
  • Table 160. France Ketoconazole, by Application USD Million (2025-2030)
  • Table 161. France Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 162. Italy Ketoconazole, by Type USD Million (2025-2030)
  • Table 163. Italy Ketoconazole, by Application USD Million (2025-2030)
  • Table 164. Italy Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 165. United Kingdom Ketoconazole, by Type USD Million (2025-2030)
  • Table 166. United Kingdom Ketoconazole, by Application USD Million (2025-2030)
  • Table 167. United Kingdom Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 168. Netherlands Ketoconazole, by Type USD Million (2025-2030)
  • Table 169. Netherlands Ketoconazole, by Application USD Million (2025-2030)
  • Table 170. Netherlands Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 171. Rest of Europe Ketoconazole, by Type USD Million (2025-2030)
  • Table 172. Rest of Europe Ketoconazole, by Application USD Million (2025-2030)
  • Table 173. Rest of Europe Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 174. MEA Ketoconazole, by Country USD Million (2025-2030)
  • Table 175. MEA Ketoconazole, by Type USD Million (2025-2030)
  • Table 176. MEA Ketoconazole, by Application USD Million (2025-2030)
  • Table 177. MEA Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 178. Middle East Ketoconazole, by Type USD Million (2025-2030)
  • Table 179. Middle East Ketoconazole, by Application USD Million (2025-2030)
  • Table 180. Middle East Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 181. Africa Ketoconazole, by Type USD Million (2025-2030)
  • Table 182. Africa Ketoconazole, by Application USD Million (2025-2030)
  • Table 183. Africa Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 184. North America Ketoconazole, by Country USD Million (2025-2030)
  • Table 185. North America Ketoconazole, by Type USD Million (2025-2030)
  • Table 186. North America Ketoconazole, by Application USD Million (2025-2030)
  • Table 187. North America Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 188. United States Ketoconazole, by Type USD Million (2025-2030)
  • Table 189. United States Ketoconazole, by Application USD Million (2025-2030)
  • Table 190. United States Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 191. Canada Ketoconazole, by Type USD Million (2025-2030)
  • Table 192. Canada Ketoconazole, by Application USD Million (2025-2030)
  • Table 193. Canada Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 194. Mexico Ketoconazole, by Type USD Million (2025-2030)
  • Table 195. Mexico Ketoconazole, by Application USD Million (2025-2030)
  • Table 196. Mexico Ketoconazole, by Distribution Channel USD Million (2025-2030)
  • Table 197. Research Programs/Design for This Report
  • Table 198. Key Data Information from Secondary Sources
  • Table 199. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ketoconazole: by Type USD Million (2018-2023)
  • Figure 5. Global Ketoconazole: by Application USD Million (2018-2023)
  • Figure 6. Global Ketoconazole: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America Ketoconazole Share (%), by Country
  • Figure 8. Asia Pacific Ketoconazole Share (%), by Country
  • Figure 9. Europe Ketoconazole Share (%), by Country
  • Figure 10. MEA Ketoconazole Share (%), by Country
  • Figure 11. North America Ketoconazole Share (%), by Country
  • Figure 12. Global Ketoconazole share by Players 2023 (%)
  • Figure 13. Global Ketoconazole share by Players (Top 3) 2023(%)
  • Figure 14. Global Ketoconazole share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 17. Mylan (United States) Revenue: by Geography 2023
  • Figure 18. Almirall (Spain) Revenue, Net Income and Gross profit
  • Figure 19. Almirall (Spain) Revenue: by Geography 2023
  • Figure 20. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 21. Johnson & Johnson (United States) Revenue: by Geography 2023
  • Figure 22. Taro Pharmaceutical (Israel) Revenue, Net Income and Gross profit
  • Figure 23. Taro Pharmaceutical (Israel) Revenue: by Geography 2023
  • Figure 24. Teva Pharmaceutical (Israel) Revenue, Net Income and Gross profit
  • Figure 25. Teva Pharmaceutical (Israel) Revenue: by Geography 2023
  • Figure 26. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. Novartis (Switzerland) Revenue: by Geography 2023
  • Figure 28. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2023
  • Figure 30. Amgen (United States) Revenue, Net Income and Gross profit
  • Figure 31. Amgen (United States) Revenue: by Geography 2023
  • Figure 32. AbbVie (United States) Revenue, Net Income and Gross profit
  • Figure 33. AbbVie (United States) Revenue: by Geography 2023
  • Figure 34. Merck & Co (United States) Revenue, Net Income and Gross profit
  • Figure 35. Merck & Co (United States) Revenue: by Geography 2023
  • Figure 36. Global Ketoconazole: by Type USD Million (2025-2030)
  • Figure 37. Global Ketoconazole: by Application USD Million (2025-2030)
  • Figure 38. Global Ketoconazole: by Distribution Channel USD Million (2025-2030)
  • Figure 39. South America Ketoconazole Share (%), by Country
  • Figure 40. Asia Pacific Ketoconazole Share (%), by Country
  • Figure 41. Europe Ketoconazole Share (%), by Country
  • Figure 42. MEA Ketoconazole Share (%), by Country
  • Figure 43. North America Ketoconazole Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Mylan (United States)
  • Almirall (Spain)
  • Johnson & Johnson (United States)
  • Taro Pharmaceutical (Israel)
  • Teva Pharmaceutical (Israel)
  • Novartis (Switzerland)
  • GlaxoSmithKline (United Kingdom)
  • Amgen (United States)
  • AbbVie (United States)
  • Merck & Co (United States)
Additional players considered in the study are as follows:
Strides Pharma (India) , Parchem (United States) , Ciron Drugs and Pharmaceuticals P Ltd (India) , Bristol-Myers Squibb (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 250 Pages 95 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Ketoconazole Market Quantitative research analysis
Global Ketoconazole Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Mylan (United States), Almirall (Spain), Johnson & Johnson (United States), Taro Pharmaceutical (Israel), Teva Pharmaceutical (Israel), Novartis (Switzerland), GlaxoSmithKline (United Kingdom), Amgen (United States), AbbVie (United States) and Merck & Co (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Applications as Antifungal Medication in Case of Skin, Ringworm, and Other Infections " is seen as one of major influencing trends for Ketoconazole Market during projected period 2023-2030.
The Ketoconazole market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Ketoconazole Market Report?

Have a Query? Click Here

Other Related Reports

Sulfur Powder Comprehensive Study by Type (99.5% Pure, 99.9% Pure), Application (Agriculture, Pharmaceuticals, Others), Distribution Channel (Online, Offline), Packaging (Below 1kg, 1kg to 5kg, 5kg t...
$ 3350
Ammonium Sulfite Comprehensive Study by Type (Medical Grade, Industrial Grade, Food Grade), Application (Chemical, Pharmaceutical, Cosmetics, Pulp, Food Industry, Others), Distribution Channel (Onlin...
$ 3350
Flexible Plastic Paint Comprehensive Study by Type (Single Side Tape, Double Sides Tape), Application (Electrical, Electronics, Automotive, Aerospace, Medical), End users (Electronic Products, Motorc...
$ 3450
Water Wood Paint Comprehensive Study by Type (Water-Based Acrylic Paints, Water-Based Latex Paints, Water-Based PU Paint), Application (Furniture, Flooring, Decking, Joinery, Others), Packaging Type ...
$ 3800
Soap Noodles Comprehensive Study by Application (Cosmetics, Toiletries, Fine Fragrances and Perfume, Soaps and Detergents), Ingredients (Natural Ingredients (Flower Based, Fruit Based, Wood-Based and...
$ 3650
Chlorine Dioxide Disinfectant Comprehensive Study by Type (Powder, Solution), Application (Disinfectant, Oxidizing Agent), End User (Food & Beverages, Hospitals and Healthcare Facilities, Industrial ...
$ 3350